American Heart Association
Lipid Management in the 21st Century: Progress and Promise in the Second Quarter
Abstract Poster Board Session
Population Science Zone
Nov 9th , 03:15 PM - 04:15 PM
03 : 15 PM
Efficacy and Safety of Obicetrapib in Dyslipidemia or Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis
Hemida Mohamed Fawzi, Hammad Noha, Ibrahim Alyaa, Bahnasy Ahmed, Ishtiaq Saniya, Shahriar Zahin, Hassan Mohamed Abdelrhman, Islam M Rafiqul, Younas Muhammad, Sarfraz Muhammad Raza, Ali Muhammad Faizan
Final Pr. ID: Su2129
Authors: Hemida Mohamed Fawzi, Hammad Noha, Ibrahim Alyaa, Bahnasy Ahmed, Ishtiaq Saniya, Shahriar Zahin, Hassan Mohamed Abdelrhman, Islam M Rafiqul, Younas Muhammad, Sarfraz Muhammad Raza, Ali Muhammad Faizan
Keywords: Cardiovascular Risk , Cardiovascular disease , Lipids , Cardiovascular therapeutics , Cardiovascular health
03 : 15 PM
ANGPTL3 Targeting Monoclonal Antibodies Lead to Robust Reductions in LDL-C, Triglycerides, ApoB, and Non-HDL-C in Dyslipidemic Patients: A Meta-Analysis of 5 Randomized Controlled Trials
Daid Simranpreet Singh, Sharma Anubhuti, Sharma Arundhati, Pannu Sagal, Asnani Heena, Bhanushali Karan, Choudhary Khushal, Sharma Saurabh
Final Pr. ID: Su2130
Authors: Daid Simranpreet Singh, Sharma Anubhuti, Sharma Arundhati, Pannu Sagal, Asnani Heena, Bhanushali Karan, Choudhary Khushal, Sharma Saurabh
Keywords: LDL , Cholesterol-lowering drugs , Dyslipidemia , Monoclonal antibodies , Hypercholesterolemia
03 : 15 PM
The Statin Shortfall: Lower Statin Use in Autoimmune Disease Despite Elevated Cardiovascular Risk Across LDL-C Levels.
Jaganathan Vijayadithyan, Mendpara Vaidehi, Maturi Bhanu, Venugopalan Sruthi, Ramesh Prasana, Wassif Heba
Final Pr. ID: Su2131
Authors: Jaganathan Vijayadithyan, Mendpara Vaidehi, Maturi Bhanu, Venugopalan Sruthi, Ramesh Prasana, Wassif Heba
Keywords: Autoimmune , Statins , Outcomes
Uppalapati Lakshmi, Mascarenhas Lorraine, Xiao Emily, Abushamat Layla, Minhas Abdul Mannan Khan, Levine Glenn, Jia Xiaoming, Ballantyne Christie, Misra Arunima, Nambi Vijay
Final Pr. ID: Su2132
Authors: Uppalapati Lakshmi, Mascarenhas Lorraine, Xiao Emily, Abushamat Layla, Minhas Abdul Mannan Khan, Levine Glenn, Jia Xiaoming, Ballantyne Christie, Misra Arunima, Nambi Vijay
Keywords: Lipids
03 : 15 PM
Safety and Efficacy of Moderate-Intensity Statin Plus Ezetimibe versus High-Intensity Statin in Older Adult Patients: A Meta-analysis
Joseph Meghna, Krishna Mrinal, Ezenna Chidubem, Akman Zafer, Rossi Raiza, Chi Kuan Yu, Damluji Abdulla, Goldsweig Andrew, Kutty Shelby, Nanna Michael
Final Pr. ID: Su2133
Authors: Joseph Meghna, Krishna Mrinal, Ezenna Chidubem, Akman Zafer, Rossi Raiza, Chi Kuan Yu, Damluji Abdulla, Goldsweig Andrew, Kutty Shelby, Nanna Michael
Keywords: Cholesterol-lowering drugs , Statins , Hypercholesterolemia , Elderly
03 : 15 PM
The Efficacy and Safety of Plozasiran on Lipid Profile in Dyslipidemic Disorders: A Systematic Review and Meta-Analysis
Sydhom Pishoy, Al-quraishi Bakr, Gohar Aya, El-shawaf Mohamad, Shehata Nahla, Ataya Miral, Sydhom Mark, Awwad Nouran, Motawade Haidy, Naji Nourhan, Shaaban Abdelgalil Mahmoud
Final Pr. ID: Su2134
Authors: Sydhom Pishoy, Al-quraishi Bakr, Gohar Aya, El-shawaf Mohamad, Shehata Nahla, Ataya Miral, Sydhom Mark, Awwad Nouran, Motawade Haidy, Naji Nourhan, Shaaban Abdelgalil Mahmoud
Keywords: Dyslipidemia , Lipoproteins , Triglycerides , Lipids
03 : 15 PM
Bempedoic Acid Lowers LDL-C and Reduces Risk of Major Cardiovascular Events in Hypercholesterolemia: Meta-Analysis of 13 Randomized Controlled Trials
Daid Simranpreet Singh, Sharma Anubhuti, Sharma Arundhati, Choudhary Khushal
Final Pr. ID: Su2135
Authors: Daid Simranpreet Singh, Sharma Anubhuti, Sharma Arundhati, Choudhary Khushal
Keywords: LDL , Lipids , HDL , Cholesterol
03 : 15 PM
Updated Meta-Analysis of Randomized Controlled Trials Evaluating the Safety and Efficacy of Inclisiran in Hyperlipidemia
Tahir Muhammad Waseem, Saleem Junaid, Hyder Arsalan, Shah Aresha Masood, Akram Amina, Mohid Haroon Muhammad, Kamran Ali Izma, Murali Karthikk, Tahir Zubia
Final Pr. ID: Su2136
Authors: Tahir Muhammad Waseem, Saleem Junaid, Hyder Arsalan, Shah Aresha Masood, Akram Amina, Mohid Haroon Muhammad, Kamran Ali Izma, Murali Karthikk, Tahir Zubia
Keywords: HDL , Dyslipidemia , Cardioprotective drugs , Triglycerides , LDL
03 : 15 PM
LPA-Targeted siRNAs Lower Lp(a) by Over 90%: A Meta-Analysis of Olpasiran, Lepodisiran, and Zerlasiran
Shokravi Arveen, Singh Rishav, Sharma Sohat, Taleghani Masoud
Final Pr. ID: Su2137
Authors: Shokravi Arveen, Singh Rishav, Sharma Sohat, Taleghani Masoud
Keywords: Lipoproteins , Apolipoproteins , Lipids , Atherosclerosis , Cardiovascular therapeutics
03 : 15 PM
Efficacy of Olpasiran by Apolipoprotein(a) Isoform Size: Insights from the OCEAN(a)-DOSE Trial
Monguillon Victorien, Lopez J. Antonio, Rosenson Robert, Ran Xinhui, Wang Jingying, Wang Huei, Wu You, Kassahun Helina, Sabatine Marc, O'donoghue Michelle
Final Pr. ID: Su2138
Authors: Monguillon Victorien, Lopez J. Antonio, Rosenson Robert, Ran Xinhui, Wang Jingying, Wang Huei, Wu You, Kassahun Helina, Sabatine Marc, O'donoghue Michelle
Keywords: Atherosclerosis , Lipids , Lipoproteins , Apolipoproteins
03 : 15 PM
ANGPTL3 Targeting Monoclonal Antibodies Lead to Robust Reductions in LDL-C, Triglycerides, ApoB, and Non-HDL-C in Dyslipidemic Patients: A Meta-Analysis of 5 Randomized Controlled Trials
Daid Simranpreet Singh, Sharma Anubhuti, Sharma Arundhati, Pannu Sagal, Asnani Heena, Bhanushali Karan, Choudhary Khushal, Sharma Saurabh
Final Pr. ID: Su2130
Authors: Daid Simranpreet Singh, Sharma Anubhuti, Sharma Arundhati, Pannu Sagal, Asnani Heena, Bhanushali Karan, Choudhary Khushal, Sharma Saurabh
Keywords: LDL , Cholesterol-lowering drugs , Dyslipidemia , Monoclonal antibodies , Hypercholesterolemia
03 : 15 PM
Bempedoic Acid Lowers LDL-C and Reduces Risk of Major Cardiovascular Events in Hypercholesterolemia: Meta-Analysis of 13 Randomized Controlled Trials
Daid Simranpreet Singh, Sharma Anubhuti, Sharma Arundhati, Choudhary Khushal
Final Pr. ID: Su2135
Authors: Daid Simranpreet Singh, Sharma Anubhuti, Sharma Arundhati, Choudhary Khushal
Keywords: LDL , Lipids , HDL , Cholesterol
03 : 15 PM
Efficacy and Safety of Obicetrapib in Dyslipidemia or Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis
Hemida Mohamed Fawzi, Hammad Noha, Ibrahim Alyaa, Bahnasy Ahmed, Ishtiaq Saniya, Shahriar Zahin, Hassan Mohamed Abdelrhman, Islam M Rafiqul, Younas Muhammad, Sarfraz Muhammad Raza, Ali Muhammad Faizan
Final Pr. ID: Su2129
Authors: Hemida Mohamed Fawzi, Hammad Noha, Ibrahim Alyaa, Bahnasy Ahmed, Ishtiaq Saniya, Shahriar Zahin, Hassan Mohamed Abdelrhman, Islam M Rafiqul, Younas Muhammad, Sarfraz Muhammad Raza, Ali Muhammad Faizan
Keywords: Cardiovascular Risk , Cardiovascular disease , Lipids , Cardiovascular therapeutics , Cardiovascular health
03 : 15 PM
Efficacy of Olpasiran by Apolipoprotein(a) Isoform Size: Insights from the OCEAN(a)-DOSE Trial
Monguillon Victorien, Lopez J. Antonio, Rosenson Robert, Ran Xinhui, Wang Jingying, Wang Huei, Wu You, Kassahun Helina, Sabatine Marc, O'donoghue Michelle
Final Pr. ID: Su2138
Authors: Monguillon Victorien, Lopez J. Antonio, Rosenson Robert, Ran Xinhui, Wang Jingying, Wang Huei, Wu You, Kassahun Helina, Sabatine Marc, O'donoghue Michelle
Keywords: Atherosclerosis , Lipids , Lipoproteins , Apolipoproteins
Uppalapati Lakshmi, Mascarenhas Lorraine, Xiao Emily, Abushamat Layla, Minhas Abdul Mannan Khan, Levine Glenn, Jia Xiaoming, Ballantyne Christie, Misra Arunima, Nambi Vijay
Final Pr. ID: Su2132
Authors: Uppalapati Lakshmi, Mascarenhas Lorraine, Xiao Emily, Abushamat Layla, Minhas Abdul Mannan Khan, Levine Glenn, Jia Xiaoming, Ballantyne Christie, Misra Arunima, Nambi Vijay
Keywords: Lipids
03 : 15 PM
LPA-Targeted siRNAs Lower Lp(a) by Over 90%: A Meta-Analysis of Olpasiran, Lepodisiran, and Zerlasiran
Shokravi Arveen, Singh Rishav, Sharma Sohat, Taleghani Masoud
Final Pr. ID: Su2137
Authors: Shokravi Arveen, Singh Rishav, Sharma Sohat, Taleghani Masoud
Keywords: Lipoproteins , Apolipoproteins , Lipids , Atherosclerosis , Cardiovascular therapeutics
03 : 15 PM
Safety and Efficacy of Moderate-Intensity Statin Plus Ezetimibe versus High-Intensity Statin in Older Adult Patients: A Meta-analysis
Joseph Meghna, Krishna Mrinal, Ezenna Chidubem, Akman Zafer, Rossi Raiza, Chi Kuan Yu, Damluji Abdulla, Goldsweig Andrew, Kutty Shelby, Nanna Michael
Final Pr. ID: Su2133
Authors: Joseph Meghna, Krishna Mrinal, Ezenna Chidubem, Akman Zafer, Rossi Raiza, Chi Kuan Yu, Damluji Abdulla, Goldsweig Andrew, Kutty Shelby, Nanna Michael
Keywords: Cholesterol-lowering drugs , Statins , Hypercholesterolemia , Elderly
03 : 15 PM
The Efficacy and Safety of Plozasiran on Lipid Profile in Dyslipidemic Disorders: A Systematic Review and Meta-Analysis
Sydhom Pishoy, Al-quraishi Bakr, Gohar Aya, El-shawaf Mohamad, Shehata Nahla, Ataya Miral, Sydhom Mark, Awwad Nouran, Motawade Haidy, Naji Nourhan, Shaaban Abdelgalil Mahmoud
Final Pr. ID: Su2134
Authors: Sydhom Pishoy, Al-quraishi Bakr, Gohar Aya, El-shawaf Mohamad, Shehata Nahla, Ataya Miral, Sydhom Mark, Awwad Nouran, Motawade Haidy, Naji Nourhan, Shaaban Abdelgalil Mahmoud
Keywords: Dyslipidemia , Lipoproteins , Triglycerides , Lipids
03 : 15 PM
The Statin Shortfall: Lower Statin Use in Autoimmune Disease Despite Elevated Cardiovascular Risk Across LDL-C Levels.
Jaganathan Vijayadithyan, Mendpara Vaidehi, Maturi Bhanu, Venugopalan Sruthi, Ramesh Prasana, Wassif Heba
Final Pr. ID: Su2131
Authors: Jaganathan Vijayadithyan, Mendpara Vaidehi, Maturi Bhanu, Venugopalan Sruthi, Ramesh Prasana, Wassif Heba
Keywords: Autoimmune , Statins , Outcomes
03 : 15 PM
Updated Meta-Analysis of Randomized Controlled Trials Evaluating the Safety and Efficacy of Inclisiran in Hyperlipidemia
Tahir Muhammad Waseem, Saleem Junaid, Hyder Arsalan, Shah Aresha Masood, Akram Amina, Mohid Haroon Muhammad, Kamran Ali Izma, Murali Karthikk, Tahir Zubia
Final Pr. ID: Su2136
Authors: Tahir Muhammad Waseem, Saleem Junaid, Hyder Arsalan, Shah Aresha Masood, Akram Amina, Mohid Haroon Muhammad, Kamran Ali Izma, Murali Karthikk, Tahir Zubia
Keywords: HDL , Dyslipidemia , Cardioprotective drugs , Triglycerides , LDL